Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alex Zoroufy
Observed names:
A. Zoroufy,
Zoroufy, A.
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5062873649
Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)
2022
·
Michelle Joy Naughton
, David Zahrieh
, et al.
·
Cancer Research
·
2
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
2025
·
Eileen Shinn
, David Zahrieh
, et al.
·
Breast Cancer Research and Treatment
·
1
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)
2026
·
Bjelic-Radisic, V.
, Lemieux, J.
, et al.
·
UNC Libraries
Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
2026
·
Eileen Shinn
, David Zahrieh
, et al.
·
Breast Cancer Research and Treatment
PDF
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)
2025
·
M.J. Naughton
, D.M. Zahrieh
, et al.
·
ESMO Open
PDF
Abstract P4-12-01: Adherence with adjuvant endocrine therapy with or without Palbociclib in the PALLAS trial
2022
·
Eileen Shinn
, David Zahrieh
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
